Literature DB >> 25194342

Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.

Ying Zhou1, Huqun Li1, Xiaomeng He1, Mengmeng Jia1, Yang Ni1, Mingzhen Xu1, Hui Chen2, Weiyong Li3.   

Abstract

A simple and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the simultaneous determination of clevidipine and its primary metabolite H152/81 in dog plasma after protein precipitation with acetonitrile using felodipine as the internal standard (IS). Chromatographic separation was performed on a XB C18 column (2.1mm×50mm, 3.5μm) under isocratic conditions with the mobile phase consisting of acetonitrile and 20mM ammonium acetate buffer (pH 7.0) (40:60, v/v) at the flow rate of 0.3ml/min. The run time was 5.5min. Mass spectrometric analysis was performed on a triple quadrupole mass spectrometer operated in the multiple reaction monitoring (MRM) mode with the transitions of m/z 473.0→338.2 for clevidipine, m/z 356.1→324.0 for H152/81 and m/z 383.9→338.2 for the IS. The method was fully validated in terms of selectivity, linearity, lower limit of quantification (LLOQ), accuracy, precision, stability, matrix effect and recovery over a concentration range of 0.15-200ng/ml for clevidipine and 10-2000ng/ml for H152/81, respectively. The analytical method was applied to support a pharmacokinetic study of simultaneous determination of clevidipine and H152/81 in ten healthy beagle dogs.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clevidipine; Liquid chromatography tandem mass spectrometry; Metabolite; Pharmacokinetic

Mesh:

Substances:

Year:  2014        PMID: 25194342     DOI: 10.1016/j.jpba.2014.08.018

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Simultaneous Quantitation of Clevidipine and Its Active Metabolite H152/81 in Human Whole Blood by LC-MS/MS: Application to Bioequivalence Study.

Authors:  Pengfei Li; Haitang Wu; Zhixia Zhao; Ping Du; Haitong Xu; Hongchuan Liu; Yu Zhou; Weiyue Yu; Hao Li; Lihong Liu
Journal:  Front Chem       Date:  2022-04-07       Impact factor: 5.545

2.  Pharmacokinetics and tissue distribution of clevidipine and its metabolite in dogs and rats.

Authors:  Ying Zhou; Xiao-Meng He; Hu-Qun Li; Yang Ni; Ming-Zhen Xu; Hui Chen; Wei-Yong Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.